De-escalating breast cancer surgery - Where is the tipping point? Editorial
| Authors: | Morrow, M.; Winer, E. P. |
| Title: | De-escalating breast cancer surgery - Where is the tipping point? |
| Keywords: | cancer survival; treatment outcome; treatment response; cancer recurrence; systemic therapy; united states; cancer adjuvant therapy; disease free survival; follow up; cancer incidence; sentinel lymph node biopsy; gene overexpression; breast cancer; epidermal growth factor receptor 2; cancer screening; histology; health care cost; adverse outcome; mammography; partial mastectomy; short survey; therapy effect; general practitioner; false positive result; intraductal carcinoma; lumpectomy; clinical trial (topic); molecularly targeted therapy; accelerated partial breast irradiation; triple negative breast cancer; radiology department; ambulatory surgery; fine needle aspiration biopsy; her2 gene; hypofractionated radiotherapy; low risk population; disease burden; human |
| Journal Title: | JAMA Oncology |
| Volume: | 6 |
| Issue: | 2 |
| ISSN: | 2374-2437 |
| Publisher: | American Medical Association |
| Date Published: | 2020-02-01 |
| Start Page: | 183 |
| End Page: | 184 |
| Language: | English |
| DOI: | 10.1001/jamaoncol.2019.4849 |
| PUBMED: | 31830209 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Short Survey -- Export Date: 1 April 2020 -- Source: Scopus |
